Foreign drug companies to launch less new drugs in 2006.

A lot of new drugs seems to be launched this year by the foreign multinational drug corporations although many of them struggled hard against the market entries of generic drugs.

Pfizer Korea introduced Spiriva (COPD), Zeldox (schizophrenia) and Vfend (anti-fungal) last year and will introduce Carduet, a combined drug of Novarsc plus Lipitor and Lyrica, a neurotic pain and anti-epileptic ...